Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
BMC Cancer|May 13, 2021
Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasionNarendra V Sankpal, Taylor C Brown, Timothy P Fleming, et al.Plos One|May 16, 2023
Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1Fatma A Omar, Taylor C Brown, William E Gillanders, et al.BMC Cancer|July 2, 2025
Landscape of cancer associated EpCAM mutations: molecular modeling, predictive insights and impact on patient survivalPriyanka S Dhotare, Audrey C Bochi-Layec, Timothy P Fleming, et al.Transplantation|September 4, 2024
Downregulation of Tumor Suppressor Gene LKB1 During Severe Primary Graft Dysfunction After Human Lung Transplantation: Implication for the Development of Chronic Lung Allograft DysfunctionMohammad Rahman, Davide Scozzi, Natsuki Eguchi, et al.Journal of Experimental & Clinical Cancer Research : CR|January 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerYassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal, et al.Cellular Immunology|February 22, 2023
Downregulation of a tumor suppressor gene LKB1 in lung transplantation as a biomarker for chronic murine lung allograft rejectionMohammad Rahman, Ranjithkumar Ravichandran, Narendra V Sankpal, et al.Respiratory Research|March 23, 2025
Alveolar epithelial type 2 cell specific loss of IGFBP2 activates inflammation in COVID-19Valentina Pujadas, Chiahsuan Chin, Narendra V Sankpal, et al.Frontiers in Molecular Biosciences|August 30, 2024
Enhanced enrichment of extracellular vesicles for laboratory and clinical research from drop-sized blood samplesAlexa Guerrero-Alba, Sandhya Bansal, Aryan N Sankpal, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 2010
Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancerJennifer L Gnerlich, Jonathan B Mitchem, Joshua S Weir, et al.Cancer Immunology Research|February 6, 2026
Neoadjuvant endocrine treatment plus mammaglobin-A DNA vaccine induces antitumor immune responses in the primary tumor and peripheral blood of breast cancer patients: Insights from a phase 1b clinical trialRashmi Mishra, Foluso Ademuyiwa, Yilin Yang, et al.Pageof 3